Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519616) titled 'Effect of Escherichia Coli 5C (Colipral(R)) on Post-Colonoscopy Gastrointestinal Symptoms' on April 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Liaquat University of Medical & Health Sciences

Condition: Post-Colonoscopy Gastrointestinal Symptoms

Intervention: Dietary Supplement: Colipral(R)

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: April 27, 2026

Target Sample Size: 160

Countries of ...